End-of-day quote
Colombo S.E.
23:00:00 23/06/2024 BST
|
5-day change
|
1st Jan Change
|
674.8
LKR
|
-0.15%
|
|
+0.78%
|
+3.81%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
600
|
600
|
1,200
|
1,278
|
921
|
975
|
Enterprise Value (EV)
1 |
680.7
|
653.2
|
1,180
|
1,292
|
978.9
|
891.9
|
P/E ratio
|
12.3
x
|
8
x
|
11.1
x
|
7.44
x
|
5.69
x
|
3.95
x
|
Yield
|
3.25%
|
5.25%
|
3.62%
|
2.93%
|
5.21%
|
6.92%
|
Capitalization / Revenue
|
0.69
x
|
0.63
x
|
1.17
x
|
0.8
x
|
0.55
x
|
0.6
x
|
EV / Revenue
|
0.78
x
|
0.68
x
|
1.15
x
|
0.81
x
|
0.58
x
|
0.55
x
|
EV / EBITDA
|
8.25
x
|
5.55
x
|
7.13
x
|
5.5
x
|
2.27
x
|
2.59
x
|
EV / FCF
|
-7.12
x
|
17.1
x
|
-22.6
x
|
-26,500
x
|
9.26
x
|
6.37
x
|
FCF Yield
|
-14%
|
5.85%
|
-4.42%
|
-0%
|
10.8%
|
15.7%
|
Price to Book
|
1.11
x
|
1.01
x
|
1.82
x
|
1.63
x
|
1.01
x
|
0.88
x
|
Nbr of stocks (in thousands)
|
1,500
|
1,500
|
1,500
|
1,500
|
1,500
|
1,500
|
Reference price
2 |
400.0
|
400.0
|
800.1
|
852.0
|
614.0
|
650.0
|
Announcement Date
|
29/05/19
|
29/07/20
|
17/05/21
|
20/05/22
|
19/05/23
|
15/05/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
874.4
|
955.8
|
1,026
|
1,597
|
1,678
|
1,613
|
EBITDA
1 |
82.52
|
117.7
|
165.4
|
234.9
|
430.8
|
344.1
|
EBIT
1 |
69.27
|
107.4
|
150.8
|
208.8
|
405.9
|
323.5
|
Operating Margin
|
7.92%
|
11.24%
|
14.69%
|
13.08%
|
24.19%
|
20.06%
|
Earnings before Tax (EBT)
1 |
65.57
|
104.1
|
151.5
|
203.1
|
222
|
356.9
|
Net income
1 |
48.68
|
75.01
|
108.1
|
171.7
|
161.7
|
246.9
|
Net margin
|
5.57%
|
7.85%
|
10.54%
|
10.75%
|
9.64%
|
15.31%
|
EPS
2 |
32.46
|
50.01
|
72.08
|
114.5
|
107.8
|
164.6
|
Free Cash Flow
1 |
-95.59
|
38.2
|
-52.14
|
-0.0488
|
105.7
|
140
|
FCF margin
|
-10.93%
|
4%
|
-5.08%
|
-0%
|
6.3%
|
8.68%
|
FCF Conversion (EBITDA)
|
-
|
32.47%
|
-
|
-
|
24.54%
|
40.69%
|
FCF Conversion (Net income)
|
-
|
50.93%
|
-
|
-
|
65.36%
|
56.71%
|
Dividend per Share
2 |
13.00
|
21.00
|
29.00
|
25.00
|
32.00
|
45.00
|
Announcement Date
|
29/05/19
|
29/07/20
|
17/05/21
|
20/05/22
|
19/05/23
|
15/05/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
80.7
|
53.2
|
-
|
13.9
|
57.9
|
-
|
Net Cash position
1 |
-
|
-
|
20.2
|
-
|
-
|
83.1
|
Leverage (Debt/EBITDA)
|
0.9783
x
|
0.4517
x
|
-
|
0.059
x
|
0.1343
x
|
-
|
Free Cash Flow
1 |
-95.6
|
38.2
|
-52.1
|
-0.05
|
106
|
140
|
ROE (net income / shareholders' equity)
|
9.29%
|
13.2%
|
17.3%
|
23.8%
|
19.1%
|
24.5%
|
ROA (Net income/ Total Assets)
|
6.58%
|
9.38%
|
12.1%
|
13.3%
|
20.3%
|
15.2%
|
Assets
1 |
740.1
|
800.1
|
891.7
|
1,291
|
796.2
|
1,624
|
Book Value Per Share
2 |
360.0
|
395.0
|
439.0
|
523.0
|
606.0
|
740.0
|
Cash Flow per Share
2 |
1.280
|
6.050
|
38.60
|
51.10
|
51.00
|
58.40
|
Capex
1 |
60.3
|
56.5
|
186
|
34.4
|
2.8
|
43
|
Capex / Sales
|
6.9%
|
5.91%
|
18.17%
|
2.15%
|
0.17%
|
2.66%
|
Announcement Date
|
29/05/19
|
29/07/20
|
17/05/21
|
20/05/22
|
19/05/23
|
15/05/24
|
|
1st Jan change
|
Capi.
|
---|
| +3.81% | 3.32M | | +21.59% | 68.87B | | -6.07% | 46.12B | | +24.77% | 44.85B | | +31.57% | 27.9B | | +8.81% | 19.38B | | +15.37% | 17.2B | | -13.50% | 14.68B | | -28.13% | 14.14B | | -33.19% | 11.49B |
Other Specialty Chemicals
|